• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 25
    • Directory
    • Microsites
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 25
  • Directory
  • Microsites
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    DCAT Week ’19

    Temperature-Controlled Logistics

    Reducing Pill Burden

    Nasal Drug Delivery

    AI in Pharma: Transforming Data into Drugs
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    Nestlé Health Licenses Codexis’ CDX-6114

    SK, Arvelle Sign $530M Deal for Antiepileptic Drug

    GS1 Delivers Lightweight Messaging Standard For Verification of Product Identifiers

    Progenics Launches Mfg. Ops in NJ

    Charles River to Pay $510M for Citoxlab
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    Progenics Launches Mfg. Ops in NJ

    Pelican BioThermal Opens New Network Location

    Reed-Lane Facility Tour

    Haselmeier Acquires Drug Manufacturing License

    Emerald Health, Lonza Enter Large-Scale Mfg. Pact
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    GS1 Delivers Lightweight Messaging Standard For Verification of Product Identifiers

    Pelican BioThermal Opens New Network Location

    Reed-Lane Facility Tour

    Recipharm Facilities Ready for EU Serialization

    Andrew Alliance, Sartorius Launch Research Solution
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    Nestlé Health Licenses Codexis’ CDX-6114

    Personalized Medicine: Getting More Out of Clinical Trials

    SK, Arvelle Sign $530M Deal for Antiepileptic Drug

    Charles River to Pay $510M for Citoxlab

    West, Swissfillon Enter Drug Delivery Partnership
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    Former FDA Senior Executives Join PAREXEL

    Top Global Pharma Company to Implement ValGenesis' VLMS

    WCG, Prudentia Enter Pharmacovigilance Alliance

    ValGenesis VLMS Chosen to Digitize Validation Process

    Serialization Compliance: Understanding the Challenges
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    Alcami

    Jubilant HollisterStier Contract Manufacturing & Services

    Ascendia Pharmaceuticals

    Ajinomoto Bio-Pharma Services

    Federal Equipment Company
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    Reed-Lane, Inc.

    Alcami

    Vetter Pharma International GmbH

    Jubilant HollisterStier Contract Manufacturing & Services

    Emergent BioSolutions, Inc.
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
      • Top 20 Pharma & BioPharma
      • Top 10 BioPharma Companies
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • White Papers
    • Infographics
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Agenda
      • Conference Sessions
    • Supplier Microsite
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Breaking News

    Vitruvias and Bora Form Contract Manufacturing Agreement

    Vitruvias licenses Potassium Chloride ER ANDA capsules to be manufactured at Bora’s new Zhunan facility in Taiwan

    Related CONTENT
    • Recipharm Acquires Sanofi’s UK CMO Biz
    • FDA Approves GW Pharma's Epidiolex
    • Prestige BioPharma, Alvogen Enter Agreement
    • Prestige BioPharma, Alvogen Enter Agreement
    • 18 ALLERGAN
    12.05.18
    Vitruvias Therapeutics, an Auburn, AL-based finished-dose generic drug development company, has agreed to license an approved Potassium Chloride Extended release ANDA. The product will be manufactured by contract development and manufacturing organization (CDMO) Bora Pharmaceutical’s Zhunan site, which was recently acquired from Impax.
     
    “As a 40-year veteran if this industry, I have toured many manufacturing facilities, and Bora’s Zhunan facility is one of the best I have ever seen,” said Carl Whatley, chief executive officer, Vitruvias. “Being a relatively new facility and having the responsibility and FDA approval for the manufacturing of Impax’s U.S. products, its size, quality systems, state-of-the-art high volume equipment and highly responsive personnel make it a logical choice for our portfolio of technically complex oral solids.”
     
    Bobby Sheng, chief executive officer, Bora Pharmaceuticals,” said, “Bora Pharmaceuticals is honored to be in business with Vitruvias. Their experienced management team has a stellar track record of successful product launches and their pipeline of products has positioned the company for explosive growth. We are excited to show our large-scale solvent capabilities and to give Vitruvias a high-quality competitive product in the market. We look forward to a long-term relationship with them.”
     
    Potassium Chloride Extended Release tablets are used to prevent or to treat low blood levels of potassium (hypokalemia). Current annual sales of all forms of Potassium Chloride Extended Release tablets totaled approximately 1.66 billion tablets through September 2018.
     
    This is the first contract manufacturing agreement between Vitruvias and Bora.
    Related Searches
    • license
    • quality
    • Capsules
    • chief executive officer
    Suggested For You
    Sun Pharma Acquires Pola Pharma in Japan Sun Pharma Acquires Pola Pharma in Japan
    Reed-Lane, Inc. Reed-Lane, Inc.
    MEGGLE GmbH & Co. KG MEGGLE GmbH & Co. KG
    Janssen Receives FDA Approval for INVOKANA Janssen Receives FDA Approval for INVOKANA
    Alcami Collaborates with Medicines Development for Global Health Alcami Collaborates with Medicines Development for Global Health
    Novatek Becomes Approved Supplier of Baxter Novatek Becomes Approved Supplier of Baxter
    Reporting CPPs to FDA Reporting CPPs to FDA
     Symbiosis Secures FDA Approval Symbiosis Secures FDA Approval
    Emergent BioSolutions Emergent BioSolutions
    CDMOs and Drug Shortages CDMOs and Drug Shortages
    Who is Responsible for Manufacturing Technology Innovation? Who is Responsible for Manufacturing Technology Innovation?
    ABEC Receives Certification from China ABEC Receives Certification from China
    FDA Approves Grifols FDA Approves Grifols' Facility for Production of Recombinant Proteins
    Rockwell Medical Announces FDA Approval Rockwell Medical Announces FDA Approval
    07	GlaxoSmithKline 07 GlaxoSmithKline

    Related Breaking News

    • Breaking News | Drug Development | Industry News
      Nestlé Health Licenses Codexis’ CDX-6114

      Nestlé Health Licenses Codexis’ CDX-6114

      Novel, oral enzyme for phenylketonuria is Codexis’ first internally developed biotherapeutic candidate
      02.19.19

    • Bio News | Breaking News | Collaborations & Alliances | Drug Development | Industry News
      SK, Arvelle Sign $530M Deal for Antiepileptic Drug

      SK, Arvelle Sign $530M Deal for Antiepileptic Drug

      Mark Altmeyer named president and chief executive of Arvelle
      02.15.19

    • Breaking News | Industry News | Packaging & Tracking | Serialization | Supply Chain
      GS1 Delivers Lightweight Messaging Standard For Verification of Product Identifiers

      GS1 Delivers Lightweight Messaging Standard For Verification of Product Identifiers

      Streamlined framework leverages GS1 Digital Link and JavaScript Object Notation (JSON)
      02.15.19


    • Breaking News | Facilities | Industry News
      Progenics Launches Mfg. Ops in NJ

      Progenics Launches Mfg. Ops in NJ

      Acquires Azedra radiopharmaceutical manufacturing facility in Somerset
      02.15.19

    • Breaking News | CRO News | Industry News | Preclinical Outsourcing
      Charles River to Pay $510M for Citoxlab

      Charles River to Pay $510M for Citoxlab

      Strengthens position in early-stage CRO space
      02.15.19

    • Breaking News | Collaborations & Alliances | Drug Delivery | Industry News
      West, Swissfillon Enter Drug Delivery Partnership

      West, Swissfillon Enter Drug Delivery Partnership

      Partner on integrated solution for clinical filling of SmartDose drug delivery platform cartridges
      02.15.19


    • Breaking News | Collaborations & Alliances | Drug Discovery | Industry News
      Jubilant Biosys, Sanofi Expand Collaboration

      Jubilant Biosys, Sanofi Expand Collaboration

      Collaboration aimed at discovery of small molecule inhibitors targeting neurological disorders
      02.15.19

    • Bio News | Industry News | Promotions & Moves | Regulatory Affairs
      Former FDA Senior Executives Join PAREXEL

      Former FDA Senior Executives Join PAREXEL

      The industry veterans will work on the company's Regulatory Consulting group
      02.15.19

    • Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News | Laboratory Testing | R&D
      Passage Bio Officially Launches

      Passage Bio Officially Launches

      With $115.5M Series A, to develop AAV-delivered therapeutics to treat rare monogenic CNS diseases
      02.15.19


    • Bio News | Collaborations & Alliances | Drug Development | Industry News | Methods Development | R&D
      Axovant Announces Formation of Arvelle Therapeutics

      Axovant Announces Formation of Arvelle Therapeutics

      Along with the strategic transition of legacy small molecule team into the newly formed company
      02.15.19

    • Bio News | Cold Chain Management | Facilities | Industry News | Supply Chain
      Pelican BioThermal Opens New Network Location

      Pelican BioThermal Opens New Network Location

      New facility in Jeddah, Saudi Arabia aims to bring convenient, flexible shipping options to the region renowned for its temperature challenges
      02.15.19

    • Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News | R&D
      AbCellera & Novartis Announce Collaboration

      AbCellera & Novartis Announce Collaboration

      AbCellera to apply technology to advance programs on up to ten targets elected by Novartis
      02.15.19

    • Financial Reports
      Financial Report: BASi

      Financial Report: BASi

      Seventh Wave acquisition drives growth in the quarter
      02.14.19

    • Breaking News | Financial Reports
      Financial Report: West Pharmaceutical Services

      Financial Report: West Pharmaceutical Services

      Revenues up 2% in the quarter, partially offset by the voluntary recall of Vial2Bag
      02.14.19

    • Bio News | Industry News | Promotions & Moves
      Catalent Appoints President & COO

      Catalent Appoints President & COO

      SVP of global operations, Alessandro Maselli, was promoted to the newly appointed positions
      02.14.19

    Breaking News
    • Nestlé Health Licenses Codexis’ CDX-6114
    • SK, Arvelle Sign $530M Deal for Antiepileptic Drug
    • GS1 Delivers Lightweight Messaging Standard For Verification of Product Identifiers
    • Progenics Launches Mfg. Ops in NJ
    • Charles River to Pay $510M for Citoxlab
    View Breaking News >
    CURRENT ISSUE

    January/February 2019

    • DCAT Week ’19
    • Temperature-Controlled Logistics
    • Reducing Pill Burden
    • Nasal Drug Delivery
    • AI in Pharma: Transforming Data into Drugs
    • Digitization: Pharma 4.0
    • Serialization Compliance: Understanding the Challenges
    • FDA & Data Integrity
    • Rising Demand for Lyophilized Products
    • Future Trends in the CDMO Space
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • privacy policy
    • term and condition
    • about us
    • contact us

    follow us

    Subscribe

    magazines

    Image
    Image
    Image
    Image
    Image
    Image
    Image
    Image
    Image
    Image
    Image

    Copyright © 2019 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login